Showing results (101-110 of 124) with videos related to
Sort By:
Pageof 13
REC, Interventional Cardiology|December 3, 2025
Telematic intervention on frailty in patients undergoing TAVI. Design of the TELE-FRAIL TAVI clinical trialEva Bernal-Labrador, Rafael Romaguera, Sergio García-Blas, et al.Revista Espanola De Cardiologia (English Ed.)|January 1, 2025
Rationale and design of the beta-blockers in tako-tsubo syndrome study: a randomized clinical trial (β-Tako)Fernando Alfonso, Jorge Salamanca, Iván Núñez-Gil, et al.Revista Espanola De Cardiologia (English Ed.)|June 30, 2018
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or PrasugrelSergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, et al.Revista Espanola De Cardiologia (English Ed.)|July 26, 2024
Efficacy and safety of bempedoic acid in acute coronary syndrome. Design of the clinical trial ES-BempeDACSSergio Raposeiras-Roubín, Emad Abu-Assi, José Ángel Pérez Rivera, et al.Revista Espanola De Cardiologia (English Ed.)|July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary SyndromeSergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.Angiology|December 4, 2019
Outcome of Patients With Prior Stroke/Transient Ischemic Attack and Acute Coronary SyndromesDongfeng Zhang, Xiantao Song, Yalei Chen, et al.The Lancet. Digital Health|October 17, 2025
Extension of the GRACE score for non-ST-elevation acute coronary syndrome: a development and validation study in ten countriesFlorian A Wenzl, Klaus F Kofoed, Moa Simonsson, et al.Thrombosis Research|June 2, 2018
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registryCarme Guerrero, Alberto Garay, Albert Ariza-Solé, et al.Circulation|November 7, 2025
Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempeDACS Randomized Clinical TrialSergio Raposeiras Roubín, Emad Abu Assi, César Jiménez Méndez, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|January 31, 2016
BleeMACS: rationale and design of the studyFabrizio D'Ascenzo, Emad Abu-Assi, Sergio Raposeiras-Roubín, et al.Pageof 13